Wei Sang
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 1%
- Nanoplatforms for cancer theranostics
Papers in
-
- Nanoplatforms for cancer theranostics 24
- Co-authors
- Yunlu Dai (25 shared papers)Zhan Zhang (22 shared papers)Jie Li (17 shared papers)Lisi Xie (16 shared papers)Bei Li (15 shared papers)Jie Yan (11 shared papers)Wenxi Li (15 shared papers)Hao Tian (15 shared papers)
- Journals
- Frontiers in Immunology (8 papers)Journal of Nuclear Materials (5 papers)Advanced Science (4 papers)Nano Research (4 papers)Frontiers in Oncology (4 papers)
- Partner nations
- ChinaMacaoUnited States
In The Last Decade
Wei Sang
179 papers receiving 5.7k citations
Wei Sang's Hit Papers
Peers
Comparison fields: 5 of 147
- Biomaterials 642
- Biomedical Engineering 2.0k
- Renewable Energy, Sustainability and the Environment 714
- Immunology 809
- Biochemistry 203
Countries citing papers authored by Wei Sang
This map shows the geographic impact of Wei Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Sang more than expected).
Fields of papers citing papers by Wei Sang
This network shows the impact of papers produced by Wei Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Sang. The network helps show where Wei Sang may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Sang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recent advances in nanomaterial-based synergistic combination cancer immunotherapy Hit paper breakdown → | 2019 | 360 |
| 2 | 2015 | 322 | |
| 3 | Phototheranostic Metal-Phenolic Networks with Antiexosomal PD-L1 Enhanced Ferroptosis for Synergistic Immunotherapy Hit paper breakdown → | 2022 | 261 |
| 4 | 2017 | 226 | |
| 5 | Engineering Radiosensitizer‐Based Metal‐Phenolic Networks Potentiate STING Pathway Activation for Advanced Radiotherapy Hit paper breakdown → | 2021 | 215 |
| 6 | 2009 | 207 | |
| 7 | 2021 | 173 | |
| 8 | 2009 | 157 | |
| 9 | 2021 | 151 | |
| 10 | 2021 | 148 | |
| 11 | 2022 | 143 | |
| 12 | 2020 | 140 | |
| 13 | 2019 | 136 | |
| 14 | 2020 | 135 | |
| 15 | 2018 | 132 | |
| 16 | 2015 | 126 | |
| 17 | 2020 | 117 | |
| 18 | 2022 | 92 | |
| 19 | 2019 | 68 | |
| 20 | 2023 | 63 |
About Wei Sang
Wei Sang is a scholar working on Molecular Biology, Biomedical Engineering, Oncology, Organic Chemistry and Materials Chemistry, having authored 189 papers that have together received 5.8k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (24 papers), Lymphoma Diagnosis and Treatment (17 papers), CAR-T cell therapy research (14 papers), Asymmetric Hydrogenation and Catalysis (11 papers), Wheat and Barley Genetics and Pathology (10 papers), Hematopoietic Stem Cell Transplantation (9 papers), Immunotherapy and Immune Responses (9 papers) and Electrocatalysts for Energy Conversion (9 papers). The work is most often cited by research in Biomaterials (642 citations), Biomedical Engineering (2.0k citations), Renewable Energy, Sustainability and the Environment (714 citations), Immunology (809 citations) and Biochemistry (203 citations). Wei Sang has collaborated with scholars based in China, Macao and United States. Frequent co-authors include Yunlu Dai, Zhan Zhang, Jie Li, Lisi Xie, Bei Li, Jie Yan, Wenxi Li, Hao Tian, Yang Yao and Guixing Ren. Their work appears in journals such as Frontiers in Immunology, Journal of Nuclear Materials, Advanced Science, Nano Research and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.